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ABSTRACT 
The aim of this study was to formulate and evaluate the oral fast-dissolving film of Vitamin B6 for the effective management of motion sickness 
and vomiting during pregnancy. Fast-dissolving films were prepared by the solvent-casting method using different polymers, HPMC-15 and 
Pullulan, along with Propylene glycol as a plasticizer. The Fourier-transform infrared study for the drug-polymer interaction was carried out. 
Evaluation of physical parameters such as physical appearance, surface texture, uniformity of weight, uniformity of strip thickness, surface pH, 
folding endurance, uniformity of drug content and percentage of moisture absorption were performed. Kinetic data analysis for  the release 
study and the stability study were also performed. Results of uniformity of weight, thickness, folding endurance, surface pH,  percentage drug 
content, tensile strength and percentage elongation of all the films were found to be satisfactory. The Fourier-transform infrared study 
indicated that there was no interaction between the drug and the polymers. The in-vitro drug release study showed that a better rate of drug 
release was achieved by formulations F4 and F8 compared with other formulations. The stability study did not show any significant difference 
in the external appearance, the drug content and the in-vitro drug release. In conclusion present study suggested that fast dissolving films has a 
better ability to cross the sublingual barrier at a faster rate, and hence the delivery system was found to be promising as it has the potential of 
overcoming the drawbacks associated with tablet formulations available in the market presently.  
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INTRODUCTION 
Oral route is the most preferred route for the delivery of the 
drugs till date as it bears various advantages over the other 
route of drug administration, but oral drug delivery systems 
still need some advancements to be made because of their 
some drawbacks related to particular class of patients which 
includes geriatric, pediatric and dysphasic patients 
associated with many medical conditions as they have 
difficulty in swallowing or chewing solid dosage forms. Many 
pediatric and geriatric patients are unwilling to take solid 
preparations due to fear of choking.1 Even with fast 
dissolving tablets there is a fear of choking due to its tablet 
type appearance. One study showed that 26% of 1576 
patients experienced difficulty in swallowing tablets. The 
most common complaint was tablet size, followed by surface 
form and taste. The problem of swallowing tablets was more 
evident in geriatric and pediatric patients, as well as 
travelling patients who may not have ready access to water.2 
So, fast-dissolving drug-delivery systems came into existence 
in the late 1970’s as an alternative to tablets, capsules and 
syrups for pediatric and geriatric patients who experience 
difficulties in swallowing traditional oral solid-dosage forms. 
These systems consist of the solid dosage forms that 
disintegrate and dissolve quickly in the oral cavity without 
the administration of water. Research and development in 
the oral drug delivery segment has led to transition of dosage 
forms from simple conventional tablets or capsules to 
modified release tablets or capsules to oral disintegrating 
tablet (ODT) to wafer to the recent development of oral fast 
dissolving films (OFDFs). Amongst the plethora of avenues 
explored for the rapid drug releasing products, oral strip 
technology is gaining much attention.3 
MATERIALS AND METHODS 
Preparation of mouth dissolving oral film by direct 
solvent casting method  
Formulation of fast-dissolving films4 
In the present study, fast-dissolving films of Vitamin B6 were 
prepared by a solvent casting technique. Flat, square-shaped, 
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aluminum foil-coated glass molds having a surface area of 25 
cm2 were fabricated for casting the films. 
Preparation of casting solutions 
The weighed quantities of polymers were kept for swelling 
overnight in distilled water and dissolved (heated, if 
necessary). The drug, superdisintegrants and aspartame 
were dissolved in distilled water and added to the above 
mentioned polymer solution along with propylene glycol as a 
plasticizer, mixed thoroughly to form a homogenous mixture. 
The volume was made up to 10 ml with distilled water. 
Entrapped air bubbles were removed by applying vacuum. 
Preparation of fast-dissolving films5 
The casting solution (10 ml) was poured into glass molds 
and dried at 40°C in a vacuum oven for 24 hour for solvent 
evaporation. The patches were removed by peeling and cut 
into a square dimension of 5 cm × 5 cm (25cm2). These 
patches were kept in a desiccator for 2 days for further 
drying and wrapped in aluminium foil, and packed in self-
sealing covers. Fast-dissolving films were prepared with 
different polymers and ratios by maintaining the 
concentration of the plasticizer and sweetener constant 
Table 1. 
 
Table 1: Formulation development of Vitamin B6 fast dissolving oral film by solvent casting method  
Formula code F1 F2 F3 F4 
 
F5 
 
F6 
 
F7 
 
F8 
Vitamin B6 (mg) 50 50 50 50 50 50 50 50 
Crospovidone (mg) 10 20 -- -- 10 20 -- -- 
Mango peel pectin (mg) -- -- 10 20 -- -- 10 20 
HPMC-15 (mg) -- -- -- -- 60 60 60 60 
Pullulan gum (mg) 60 60 60 60 -- -- -- -- 
Propylene glycol (ml) 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 
Aspartame (mg) 20 20 20 20 20 20 20 20 
Menthol (mg) Q.S Q.S Q.S Q.S Q.S Q.S Q.S Q.S 
Water up to (ml) 10 10 10 10 10 10 10 10 
 
Pre-Formulation Studies 
Preformulation testing is the first step in the rational 
development of dosage forms of a drug substance. It can be 
defined as an investigation of physical and chemical 
properties of a drug substance alone and when combined 
with excipients. The overall objective of pre-formulation 
testing is to generate information useful to the formulator in 
developing stable and bioavailable dosage forms which can 
be mass produced. 
Analytical Method used in the Determination of Vitamin 
B6 
Identification of pure drug: 
Identification of Vitamin B6 was carried out by Infra-Red 
Absorption Spectrophotometer.  
Determination of λmax: 
From above mentioned standard stock solution, 0.4 ml was 
withdrawn and added to the 10 ml volumetric flask and 
diluted up to 10 ml with 0.1N HCl. Finally, sample was 
scanned in the range of 200-400 nm. UV spectrum was 
recorded and absorption maximum was found to be 292 nm 
which is shown in Fig 13 in chapter 5, and was used for the 
further analytical studies. 
Standard calibration curve of Vitamin B6 in 0.1N HCl.9 
From the stock solution 0.2, 0.4, 0.6, 0.8 and 1.0 ml solution 
was withdrawn and added in to 10 ml volumetric flask and 
finally diluted up to 10 ml with 0.1N HCl to get the solution 
with concentration of 2-10 μg/ml respectively. The 
absorbance was measured for each solution at 292 nm using 
UV-visible spectrophotometer. The graph was plotted for 
absorbance vs concentration. 
Compatibility study:  
Weighed amount of drug (3 mg) was mixed with 100mg of 
potassium bromide (dried at 40-50oC). The mixture was 
taken and compressed under 10-ton pressure in a hydraulic 
press to form a transparent pellet. The pellet was scanned by 
IR spectrophotometer. Similar procedure is followed for all 
relevant excipients used.10 
Evaluation of fast-dissolving films6,7,8 
Mass uniformity and thickness: 
Three randomly selected different films from each batch 
(2×2 cm2) were weighed individually on an electronic 
balance. The average weight of the films was calculated. The 
thickness of the films was measured by vernier caliper at 
three different positions on the film and the average was 
calculated. 
Drug content uniformity: 
A fast-dissolving film (25 cm2) was transferred into a 
graduated flask containing 100 ml of distilled water. The 
flask was shaken for 4 hour in a mechanical shaker. The 
solution was filtered and after suitable dilutions with 
distilled water, the absorbance value was measured at 292 
nm using the placebo patch (patch without drug) solution as 
a blank, and the drug content was calculated. 
Folding endurance: 
The folding endurance is expressed as the number of folds 
(number of times the film is folded at the same place) 
required to break the specimen or to develop visible cracks. 
This also gives an indication of brittleness of the film. A strip 
of 2.5 cm × 2.5 cm (6.25 cm2) was subjected to folding 
endurance by folding the patch at the same place repeatedly 
several times until a visible crack was observed, and the 
values were reported. 
Surface pH: 
The film to be tested was placed in a Petri dish and was 
moistened with 0.5 ml of distilled water and kept for 30 sec. 
The pH was noted after bringing the electrode of the pH 
meter in contact with the surface of the formulation and 
allowing equilibration for 1 min. The average of three 
determinations for each formulation was done. 
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Elongation and tensile strength: 
This mechanical property was evaluated using the Instron 
universal testing instrument with a 5kg load cell. Film strips 
in a special dimension and free from air bubbles or physical 
imperfections were held between two clamps positioned at a 
distance of 3 cm. During measurement, the strips were 
pulled by the top clamps at a rate of 100 mm/min; the force 
and elongation were measured when the film broke. Results 
from film samples, which broke at and not between the 
clamps, were not included in the calculations. Measurements 
were run in triplicate for each film. Two mechanical 
properties, namely, tensile strength and percentage 
elongation were computed for the evaluation of the film. 
Tensile strength is the maximum stress applied to a point at 
which the film specimen breaks and can be computed from 
the applied load at rupture. 
Disintegration test: 
Disintegration test was performed to ensure the 
disintegration of the film in water. One film from each 
formulation was introduced into one tube of disintegration 
apparatus IP. A disc was added into the tube. The assembly 
was suspended in a beaker containing simulated saliva and 
the apparatus was operated until the film disintegrated. 
In-vitro dissolution studies:11 
The simulated salivary fluid was taken as the dissolution 
medium to determine the drug release. 
The dissolution profile of quick release films of Vitamin B6 
was carried out in a beaker containing 30 ml of the simulated 
salivary fluid (pH 6.8) as a dissolution medium, maintained 
at 37 ± 0.5°C. The medium was stirred at 100 rpm. Aliquots 
(5 ml) of the dissolution medium were withdrawn at 2, 4, 8, 
12 and 15 minute time intervals and the same amount was 
replaced with the fresh medium. Samples were assayed 
spectrophotometrically at 292 nm. Three trials were carried 
out for all the samples and the average value was taken. The 
percentage of the drug dissolved at various time intervals 
was calculated and plotted against time. 
Mathematical modelling of drug release profile:12 
The cumulative amount of Vitamin B6 release from the 
formulated tablets at different time intervals were fitted to 
zero order kinetics, first order kinetics, Higuchi’s model and 
korsmeyer-peppas model to characterize mechanism of drug 
release. 
Zero Order Kinetics 
It describes the system in which the release rate is 
independent of its concentration. 
Qt = Q0 + K0t 
Where,     Qt = amount of drug dissolved in time t, Q0 = initial 
amount of drug in the solution 
                  K0 = zero order release constant 
If the zero order drug release kinetic is obeyed, a plot of Qt 
versus t will give straight line with a slope of K0 and an 
intercept at Q0. 
First Order Kinetic: 
It describes the drug release from the system in which the 
release rate is concentration dependant.56 
Log Qt = log Q0 + K1t/2.303 
Where, Qt = amount of drug dissolved in time 
Q0 = initial amount of drug in the solution 
K1 = first order release constant 
If the release pattern of drug follows first order kinetics, then 
a plot of log (Q0 - Qt) versus t will be straight line with a slope 
of K1/2.303 and an intercept at t= 0 of  logQ0. 
Higuchi Model  
It describes the fraction of drug release from a matrix is 
proportional to square root of time. 
Mt/M∞ = KH t1/2 
Where,       Mt and M∞ are cumulative amount of drug release 
at time t and infinite time, and  
                     KH = Higuchi dissolution constant reflection 
formulation characteristics. 
If the Higuchi model of drug release is obeyed, then a plot of 
Mt/M∞ versus t1/2 will be straight line with slope of KH. 
Korsmeyer- Peppas Model 
The power law describes the fractional drug release is 
exponentially related to the release time and adequately 
describes the release of drug from slabs, cylinders and 
spheres, as expressed in following equation.                      
Mt / M∞ = K tn 
Log (Mt / M∞) = log K + n log t 
Stability Studies13 
Stability can be defined as the capacity of drug product to 
remain within specifications established to ensure its 
identity, strength, quality, and purity. 
Importance of stability studies 
Stability studies are important for the following reasons. 
1. This is an assurance given by the manufacturer that the 
patient would receive a uniform dose throughout the 
shelf life. 
2. The drug control administration insists on 
manufacturers on conducting the stability studies, 
identity, strength, purity and quality of the drug for an 
extended period of time in the conditions of normal 
storage. 
3. Stability testing prevents the possibility of marketing 
an unstable product. Both physical and chemical 
degradation of drug can result in unstable product. 
The optimized formulation was subjected for two months 
stability study according to ICH guidelines. The selected 
formulations were packed in aluminium foil in tightly closed 
container. They were then stored at 40ºC / 75% RH for two 
months and evaluated for their permeation study. 
RESULTS AND DISCUSSION 
Standard graph of Vitamin B6 
λmax of Vitamin B6 was found to be 292 nm as it shows 
maximum absorbance in this wavelength. 
5.3 Calibration curve of Vitamin B6 
The absorbance was measured in a UV spectrophotometer at 
292 nm against 0.1N HCl. The absorbance so obtained was 
plotted and shown in the Figure 1.                     
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Figure 1: Calibration Curve of Vitamin B6 in 0.1N HCl 
Compatibility studies using FTIR 
Infra-red spectrum of drug and polymers were recorded 
over KBr disc method and obtained spectra were shown in 
the Figure 2-6. 
All the characteristic peaks of Vitamin B6 were present in the 
spectrum of drug and polymer mixture, indicating 
compatibility between drug and polymer. The spectrum 
confirmed that there is no significant change in the chemical 
integrity of the drug. There is no change in functional group 
peaks (C=O, C=N, C-S, C-N, S=O, C-Cl) of Vitamin B6 in all the 
IR-spectra.
 
 
 
Figure 2: FT-IR spectrum of pure drug (Vitamin B6) 
 
Figure 3: FT-IR of formulation F1 
 
Figure 4: FT-IR spectrum of formulation F3 
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Figure 5: FT-IR spectrum of formulation F5 
 
Figure 6: FT-IR Spectrum of formulation F7 
 
Preparation of film formulations:  
Fast-dissolving films of Vitamin B6 were prepared by the 
solvent casting method on glass molds, using Pullulan gum 
and HPMC-15 as polymers. Propylene glycol was used as a 
plasticizer and aspartame as a sweetener. Distilled water 
was used as a solvent for HPMC and Pullulan gum. Mango 
peel pectin and crospovidone was used as 
superdisintegrants. The effect of the concentration ratio of 
polymers and superdisintegrants was studied by preparing 
various formulations of fast-dissolving films. In the 
preparation, the addition of ingredients, particularly 
propylene glycol and aspartame, was followed after the 
careful evaluation of films for physical characteristics. In all 
these formulations, a constant amount of drug (50 mg) was 
maintained. The casting solution (10 ml) was poured into 25 
cm2 molds, so that each square centimetre contains 
approximately 2 mg of the drug. The concentration of 
polymers s and the concentration of other ingredients such 
as plasticizer and sweetener were kept constant. A total 
number of eight formulations were prepared.  
Evaluation of Vitamin B6 fast dissolving oral film: 
Mass uniformity, thickness and appearance:  
From the results of the tests for physical characterization 
conducted, it is observed that the weight and thickness of all 
film samples was uniform within each formulation. The 
thickness of 12 films of each formulation was determined 
using a micrometer screw gauge, and the average thickness 
was determined. The values were found to be in the range of 
120–210 μm, which is said to be acceptable for fast-
dissolving films. The films with HPMC as a polymer showed 
a slightly increase in thickness which might be due to 
increased viscosity of HPMC. Physical appearance of 
prepared film was checked simply with visual infection of 
films and by feel or touch. Films formulated from Pullulan 
gum were smooth, flexible and transparent whereas those 
prepared from HPMC-15 were slightly rough in texture, less 
flexible and translucent. The results were showed in Table 
3. 
Drug content uniformity: 
The drug content estimation was done using by UV 
spectrophotometer (Shimadzu UV-1800), at 292nm. Drug 
content of all the formulations were found between 96.81 to 
99.07 %. All the film formulations of Vitamin B6 showed 
uniform drug content as shown in Table 3.  
Folding endurance:  
The result of folding endurance is shown in Table 3. Folding 
endurance of fast dissolving film was found in the range 
250±3 to 454±3. Fast dissolving film containing Pullulan 
gum as polymer showed optimum folding endurance (more 
than 400±2) compared to formulations containing HPMC-12. 
Therefore on the basis of appearance and folding endurance, 
we can say that Pullulan gum based formulations were 
superior to HPMC-12 based formulations.  
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Table 3: Evaluation of mouth dissolving film of Vitamin B6 
Formulation Mass uniformity 
(mg)  
Thickness 
(μm) 
Appearance Drug content  Folding 
endurance 
F1 89 110±3.5 Transparent 98.81±0.002 >400 
F2 94 135±05 Transparent 98.71±0.022 >400 
F3 87 210±05 Transparent 97.76±0.021 >400 
F4 98 195±4.5 Transparent 99.07±0.015 >400 
F5 89 160±05 Translucent 98.81±0.003 <300 
F6 88 165±03 Translucent 96.81±0.032 <300 
F7 95 184±2.5 Translucent 98.46±0.042 <300 
F8 103 197±04  Translucent 98.68±0.013 <300 
 
Surface pH: 
An acidic or alkaline pH of administered dosage forms can 
irritate the buccal mucosa. The surface pH of the prepared 
fist dissolving film was found in the range of 6.7±0.3 to 
7.02±03. The measured surface pH was found to be close to 
neutral in all the formulations which means that they have 
less potential to irritate the buccal mucosa and therefore 
they should be fairly comfortable and hence, more 
acceptable by the patients. 
Elongation and tensile strength: 
The tensile strength gives an indication of the strength and 
the elasticity of the film reflected by the parameters tensile 
strength and elongation at break. A weak and soft polymer is 
characterized by low tensile strength and elongation at 
break, a hard and brittle polymer shows a moderate tensile 
strength and low elongation at break and a soft and tough 
polymer shows a high tensile strength and elongation at 
break. In this study, the effect of superdisintegrants to 
polymer ratio was observed. The percentage elongation 
increased with the decrease in the percentage of 
superdisintegrant to polymer ratio. Among the formulation 
batches, HPMC based films showed a better tensile strength 
due to the hydrophobic nature of the polymers compared to 
Pullulan gum. The percentage elongation of prepared film 
was found in the range of 36.88±1.3% to 72.15±1.4% and 
Tensile strength was found in the range of 1.28±0.06 
kg/mm2 to 1.41±0.017 kg/mm2. Results of tensile strength 
and percentage elongation are shown in Table 4. 
 
Table 4: Evaluation of mouth dissolving film of Vitamin B6 
Formulation Surface pH  Tensile strength 
Kg/mm2 
% 
Elongation 
Disintegration 
time (sec) 
F1 6.70±0.3 1.28±0.006 36.88±1.30 72 
F2 6.92±0.3 1.31±0.016 43.75±1.74 44 
F3 6.80±0.3 1.29±0.022 55.86±1.55 49 
F4 7.02±0.3 1.32±0.054 47.11±1.63 33 
F5 6.72±0.3 1.40±0.015 72.15±1.40 51 
F6 6.94±0.3 1.36±0.047 65.88±1.34 47 
F7 7.01±0.3 1.37±0.018 69.05±1.52 54 
F8 6.85±0.3 1.39±0.024 58.19±1.54 38 
 
Disintegration test: 
The disintegration time of prepared fast dissolving film was 
ranging between 33 second to 72 second and results shown 
in Table 4. Disintegration time of the films was decreased 
when the concentration of superdisintegrants were 
increased. Among the superdisintegrants used, formulation 
F4 containing 1:3 ratio of Mango peel pectin and Pullulan 
gum showed rapid disintegration i.e. 33 second. Fast 
disintegration time of formulation F4 might be due to higher 
swelling index of Mango peel pectin.  
In-vitro dissolution studies: 
From the in-vitro drug release, it was observed that 
formulations F4 containing Pullulan gum in combination 
with higher concentration of Mango peel pectin as a 
superdisintegrant showed faster drug release, and among 
the HPMC based films, formulation batch F8 showed more 
than 90% of drug release with in 15 minute. The release of 
the drug from prepared film was dependent on 
concentration of superdisintegrants used, when the 
concentration of superdisintegrants is increased, drug 
release from formulation was also increased, and this might 
be due to faster disintegration time for these formulations. 
The drug release was found to be in the following order: F4 > 
F8 > F6 > F2 > F3 > F7> F5> F1. The release profile of fast-
dissolving films was compared with that of conventional 
marketed product and it was observed that the drug release 
from fast-dissolving films was much faster than that from 
formulation. Results of in-vitro drug release studies were 
showed in Table 5 and Figure 7.  
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Table 5: In-vitro drug release studies of Vitamin B6 fast dissolving films 
Time 
in 
mins 
% cumulative drug release  
Formulation code  
F1 F2 F3 F4 F5 F6 F7 F8 Marketed 
product  
0 0 0 0 0 0 0 0 0 0 
2 14.26 17.04 15.56 33.34 16.02 18.63 16.56 28.45 8.32 
4 29.08 39.17 34.08 57.94 26.95 42.05 30.19 54.19 19.44 
8 41.79 47.12 46.94 74.59 43.79 58.89 44.28 67.01 28.57 
12 54.67 68.14 66.57 85.26 55.16 70.64 57.16 74.46 41.84 
15 65.91 83.59 80.17 98.81 72.37 92.38 76.10 95.10 59.88 
 
 
Figure 7: In-vitro drug release studies of Vitamin B6 fast dissolving films 
 
Drug Release Kinetics: 
Investigation of the drug release from the fast dissolving film 
was done by plotting the data of in-vitro release studies into 
different kinetic equations (Zero order, First order, and 
Higuchi’s equation). The release mechanism was understood 
by fitting the data to Korsemeyer Peppas model. The results 
of different release kinetics pattern and release mechanism 
of the drug from the different fast dissolving film 
formulations were showed in Table 6. 
From the kinetic studies, Table 6 the examination of 
correlation coefficient ‘r’ indicated that the drug release 
followed first order kinetics. It was found that the value of ‘r’ 
for first order ranged from 0.989-0.998, which is near to 1 
when compare to zero order (0.761-0.893) and Higuchi 
square root (0.598-0.796). So, it was understood to be 
following first order release pattern by the prepared film. In 
the present investigation, release from the hydrophilic 
polymers followed the combination of diffusion and erosion 
as the ‘n’ values ranged from 0.465 to 0.625 as per the 
Korsmeyer and Peppas model, which in turn justified the 
suitability of polymers for the preparation of fast-dissolving 
films. A result of release kinetics studies is showed in Table 
6.
 
Table 6: Release exponent values and release rate constant values for different fast dissolving film formulations 
Formula Code Korsmeyar and Peppas Higuchi 
 
First Order Zero Order 
R2 N R2 R2 R2 
F1 0.850 0.465 0.674 0.987 0.828 
F2 0.842 0.559 0.598 0.990 0.892 
F3 0.846 0.547 0.688 0.998 0.844 
F4 0.825 0.625 0.686 0.984 0.761 
F5 0.823 0.535 0.795 0.992 0.807 
F6 0.835 0.486 0.693 0.984 0.893 
F7 0.840 0.496 0.792 0.985 0.838 
F8 0.835 0.545 0.796 0.989 0.847 
R2=Regression coefficient, n= Exponential value 
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Stability studies: 
Based on the results of in-vitro release studies, formulation 
F4 and F8 were selected for short term stability study. 
Stability studies were carried out for 90 days at 45-50°C 
(75% RH) and 25-30°C (60% RH). The films were observed 
for physical changes, the percentage drug content and the 
percentage drug release. Fast-dissolving films of Vitamin B6 
were found to be physically and chemically stable and 
showed no significant change in terms of physical 
characteristics, the percentage drug content and the 
percentage drug release. 
 
Table 7: Results of short term stability of formulation F4 and F5 at 400-500C/75%RH 
Times in 
(Days) 
F4 Formulation F8 Formulation 
Drug content % CDR Drug content % CDR 
Initial 99.07 98.81 98.68 95.10 
15 99.04 98.80 98.61 95.00 
30 99.01 98.74 98.54 94.98 
45 98.89 98.70 98.47 94.95 
60 98.86 98.52 98.44 94.87 
90 98.82 98.21 98.42 94.84 
 
Table 8: Results of short term stability of formulation F4 and F5 at 250-300C/60%RH 
Times in 
(Days) 
F4 Formulation F8 Formulation 
Drug content % CDR Drug content % CDR 
Initial 99.07 98.81 98.68 95.10 
15 99.07 98.81 98.67 95.10 
30 99.05 98.78 98.63 94.99 
45 99.04 98.74 98.60 94.96 
60 98.98 98.70 98.56 94.93 
90 98.93 98.65 98.52 94.90 
 
 
CONCLUSION 
Oral drug delivery is currently the golden standard in the 
pharmaceutical industry where it is regarded as the safest, 
most convenient and an economical method of drug delivery 
having the highest patient compliance. 
The most popular dosage forms being tablets and capsules, 
one important drawback of these dosage forms however is 
the difficulty to swallow. Dysphagia or difficult in 
swallowing is seen to affect nearly 35% of the population.  
This disorder is also associated with number of medical 
conditions. Many elder persons will have difficulty in taking 
conventional dosage forms. However, geriatric, pediatric and 
mentally ill patients experience difficulty in swallowing 
conventional tablets, which leads to poor patient 
compliance. In some cases such as motion sickness, sudden 
episode of allergic attack or coughing and unavailability of 
water for swallowing tablets may become difficult. 
To overcome this hurdles, scientists have developed 
innovative drug delivery systems known as fast dissolving 
dosage form. United States Food and drug administration 
(FDA) defined fast dissolving oral film is defined as “an ultra-
thin film containing active ingredient that dissolves or 
disintegrates in the saliva at a remarkably fast rate, within 
few seconds without the aid of water or chewing’’. The faster 
the drug is going in to solution, the quicker the absorption 
and onset of clinical effect. Some drugs, which are soluble in 
saliva rapidly, absorbed from the mouth, pharynx and 
Oesophagus as the saliva passes down into the stomach thus 
avoids first pass metabolism and enhances the 
bioavailability. 
For the present study, we have selected Vitamin B6 
supplements have been used for years by conventional 
physicians as a treatment for morning sickness.  
The main aim of this work is to prepare and evaluate of fast 
dissolving film of Vitamin B6 using superdisintegrants like 
Crospovidone and Mango peel pectin and HPMC-15 and 
Pullulan gum as polymer. Eight formulations of fast 
dissolving film of Vitamin B6 were prepared by solvent 
casting method and subjected to various evaluation tests. 
All the fast dissolving films were evaluated for compatibility, 
thickness, folding endurance, tensile strength, disintegration 
time and in-vitro drug release studies.  Further the fast 
dissolving film formulations were subjected to their short 
term stability studies for three months and again subjected 
to further evaluation tests. 
Results revealed that all the formulated films showed 
acceptable thickness, percentage elongation, and physical 
properties. In-vitro release studies revealed that, the drug 
released by F4 formulation was comparatively higher release 
than the other formulations. The formulation F4 shows 
98.81% of drug release at the end of 15 min. To analyze the 
drug release mechanism from the fast dissolving film, the in-
vitro drug release data was fitted to Zero order, First order, 
Higuchi’s model equation and Korsmeyer-Peppas model. It 
was observed that the release of drug followed First order 
release kinetics and ‘n’ value indicates that release 
mechanism follows non-Fickian. 
Thus, it can be summarized that stable Vitamin B6 fast 
dissolving film were prepared successfully by using 
superdisintegrants in different ratio by solvent casting 
technique. The prepared fast dissolving films disintegrates 
in matter of seconds without need of water and enhances the 
absorption, this leads to increase in the bioavailability of 
method to enhance the dissolution rate.  
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